Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |